Pasar al contenido principal
Comisión-Europea
Apertura:
27 de Junio, 2023
Cierre:
16 de Enero, 2024
Hora de Cierre:
11:59 PM

Improved prediction, detection, and treatment approaches for comprehensive stroke management-HORIZON-JU-IHI-2023-05-03

PROPÓSITO DE LA CONVOCATORIA

Investigación / Innovación

ÁREA DE CONOCIMIENTO

-Escuela de Medicina y Ciencias de la Salud - Escuela de Ingeniería, Ciencia y Tecnología - Facultad de Ciencias Naturales

ENTE FINANCIADOR

Comisión Europea

MONTO A SUBVENCIONAR

10 000 000-12 000 000 EUR

Project(s) funded under this topic should aim at  integrating data  to allow for modelling, artificial intelligence (AI) and machine learning (ML)-based evaluation to identify groups and individual persons at risk and assure early recognition of stroke, thereby providing faster diagnosis and optimal, patient-specific treatment, resulting in better outcomes for patients. Effective, personalised and rapid care is critical and can make a substantial difference between full recovery and possible permanent impairment or death.

ExpectedOutcome:
Research and innovation (R&I) actions (projects) to be supported under this topic must aim to deliver results that contribute to all the following expected outcomes.

1,Patients will benefit from superior healthcare compared to the current standard of care through the availability of a clear pathway for prevention, diagnosis, and treatment of their stroke. This should be achieved by early and rapid diagnosis of stroke, more integrated and precise interventions, and treatment strategies with the patient in the centre.
2,Healthcare professionals will have access to integrated patients’ health data, improved visualisation, predictive computational models and clinical support decision systems for stroke, and benefit from efficient coordination among and within stages of care and clinical specialities.
3,Healthcare systems will benefit from more effective organisation of stroke management and personalisation of care delivery. This will increase treatment and care effectiveness and efficiency.
4,Researchers will benefit from access to integrated data, innovative modelling-based tools, and a more patient-centred definition of clinical outcomes after stroke (including patient reported outcome measurement and patient reported experience measurement), which will facilitate the continued improvement and development of future intervention strategies.
5,Health care systems, researchers, and industry will benefit from new innovative modelling tools enabling integration and analysis of a wider, actionable range of patient-specific data, including federated analysis of data.

Expected Impact:
•Patients will be offered accelerated access to the healthcare system through improved and holistic management of stroke including prevention, diagnosis, treatment, and rehabilitation that will lead to better outcomes for their health.
•Development of advanced visualisation approaches, connected artificial intelligence (AI)-based devices and modelling-based systems supporting health research and innovation (R&I), resulting in wider availability of personalised health interventions to end-users.
•Medical technology, pharmaceutical and biotechnology companies develop and offer integrated, advanced solutions for prevention, diagnosis, and treatment of stroke. This will facilitate coordinated decision-making by the different healthcare professionals involved in the stroke care pathway.
•Better implementation and scale up of existing treatments that have proven to be effective, ensuring wide coverage of the right treatment options for patients at the right time; also avoiding disparities in countries and regions.
•Contribute to the EC proposal for an ‘European Health Data Space’ (EHDS) by promoting better exchange of, and access to, different types of health data and data generated by health technologies.

Documents: (Check them on the webside).

 IHI JU Evaluation form for Research and Innovation Actions (single and two-stage Calls)
 IHI JU Proposal template (RIA/SP) - Part B

•Colombia is eligible as a third country, for this it must participate with the role of partner together with a consortium with at least three entities from different European/associated countries).

Project(s) funded under this topic should aim at  integrating data  to allow for modelling, artificial intelligence (AI) and machine learning (ML)-based evaluation to identify groups and individual persons at risk and assure early recognition of stroke, thereby providing faster diagnosis and optimal, patient-specific treatment, resulting in better outcomes for patients. Effective, personalised and rapid care is critical and can make a substantial difference between full recovery and possible permanent impairment or death.

ExpectedOutcome:
Research and innovation (R&I) actions (projects) to be supported under this topic must aim to deliver results that contribute to all the following expected outcomes.

1,Patients will benefit from superior healthcare compared to the current standard of care through the availability of a clear pathway for prevention, diagnosis, and treatment of their stroke. This should be achieved by early and rapid diagnosis of stroke, more integrated and precise interventions, and treatment strategies with the patient in the centre.
2,Healthcare professionals will have access to integrated patients’ health data, improved visualisation, predictive computational models and clinical support decision systems for stroke, and benefit from efficient coordination among and within stages of care and clinical specialities.
3,Healthcare systems will benefit from more effective organisation of stroke management and personalisation of care delivery. This will increase treatment and care effectiveness and efficiency.
4,Researchers will benefit from access to integrated data, innovative modelling-based tools, and a more patient-centred definition of clinical outcomes after stroke (including patient reported outcome measurement and patient reported experience measurement), which will facilitate the continued improvement and development of future intervention strategies.
5,Health care systems, researchers, and industry will benefit from new innovative modelling tools enabling integration and analysis of a wider, actionable range of patient-specific data, including federated analysis of data.

Expected Impact:
•Patients will be offered accelerated access to the healthcare system through improved and holistic management of stroke including prevention, diagnosis, treatment, and rehabilitation that will lead to better outcomes for their health.
•Development of advanced visualisation approaches, connected artificial intelligence (AI)-based devices and modelling-based systems supporting health research and innovation (R&I), resulting in wider availability of personalised health interventions to end-users.
•Medical technology, pharmaceutical and biotechnology companies develop and offer integrated, advanced solutions for prevention, diagnosis, and treatment of stroke. This will facilitate coordinated decision-making by the different healthcare professionals involved in the stroke care pathway.
•Better implementation and scale up of existing treatments that have proven to be effective, ensuring wide coverage of the right treatment options for patients at the right time; also avoiding disparities in countries and regions.
•Contribute to the EC proposal for an ‘European Health Data Space’ (EHDS) by promoting better exchange of, and access to, different types of health data and data generated by health technologies.

Documents: (Check them on the webside).

 IHI JU Evaluation form for Research and Innovation Actions (single and two-stage Calls)
 IHI JU Proposal template (RIA/SP) - Part B

•Colombia is eligible as a third country, for this it must participate with the role of partner together with a consortium with at least three entities from different European/associated countries).